The Indian Institute of Management, Udaipur (IIMU), successfully hosted the third edition of the D’Future: India Digital ...

Social media users are claiming that NimOset-P and Nice tablets used as painkillers have been banned by the Indian government ...

Dr. Reddy's Laboratories Ltd. closed 7.48% short of its 52-week high of 1,377.95 rupees, which the company achieved on June 12th.

Dr. Reddy's Laboratories Ltd. closed 14.19% short of its 52-week high of 1,377.95 rupees, which the company reached on June ...

Dr. Reddy's Laboratories (NYSE:RDY) reported a “resilient performance” in its fiscal third quarter of FY26, with revenue ...

Dr. Reddy’s Laboratories Limited (NYSE:RDY) Q3 2026 Earnings Call Transcript January 21, 2026 Dr. Reddy’s Laboratories ...

HYDERABAD — Dr Reddy’s Laboratories is gearing up to enter the booming global obesity drug market with a more affordable generic version of Novo Nordisk’s leading weight-loss medication, Wegovy. The ...

Drugmaker Alembic Pharma posts earnings dip on Indian labour code changes Indian drugmaker Alembic Pharmaceuticals on Thursday reported lower third‑quarter profit on Thursday after taking a one-time ...

HYDERABAD, India & PRINCETON, N.J., January 14, 2026--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as "Dr.

In trials conducted by Eli Lilly on 3,127 adults, 20% of the people who took the once-a-day pill containing the drug orforglipron, for 72 weeks, lost 20% or more of their body weight. (Unsplash/Diana ...

WASHINGTON, DC (IANS) – Drug makers Dr Reddy’s Laboratories, Sun Pharma and Aurobindo Pharma are recalling their products in the US due to manufacturing issues. According to the latest Enforcement ...

The letter follows the pre-approval inspection of the facility in September 2025 and issue of Form 483 with five observations by the U.S. FDA. The company had consequently submitted its response. “The ...